ImmuniWeb and Cortex Xpanse are both designed for cybersecurity management, with ImmuniWeb leading in cost-effectiveness and support, while Cortex Xpanse offers a richer feature set for comprehensive protection.
Features: ImmuniWeb emphasizes security testing, automated vulnerability scanning, and web monitoring, making it efficient in identifying potential threats. Cortex Xpanse offers external attack surface management, digital asset mapping, and vulnerability reporting, providing detailed insights into security vulnerabilities and helping prioritize them for enterprises.
Room for Improvement: ImmuniWeb could enhance its customer interaction and expand its feature set to match more comprehensive solutions. It may also benefit from more personalized support. Cortex Xpanse could improve its cost structure to increase affordability for smaller businesses, optimize its user interface for broader appeal, and expand support for non-English-speaking regions.
Ease of Deployment and Customer Service: Cortex Xpanse provides seamless deployment and tailored support solutions, making it advantageous for initial setup. ImmuniWeb focuses on automated solutions with moderate customer interaction, allowing straightforward deployment but less personalized assistance.
Pricing and ROI: ImmuniWeb is attractive with competitive pricing and lower setup costs, delivering high ROI for specific security needs. Cortex Xpanse, while initially costlier, offers strong long-term value through its extensive features, justifying the investment for comprehensive security.
Xpanse provides a complete, accurate and continuously updated inventory of all global internet-facing assets. This allows you to discover, evaluate, and mitigate cyber attack surface risks. You can also evaluate supplier risk and assess the security of acquired companies.
Manual asset inventory maintenance is slow and prone to error. An outside-in view of your attack surface catches assets and exposures you never knew existed to help with attack surface reduction.
Get ahead of your ransomware risk assessment by discovering and remediating RDP exposures, the leading attack vector in ransomware attacks. Find exposed assets before attackers do.
Integration with Cortex XSOAR, Prisma Cloud, and our broader portfolio allows our ASM findings to enhance security workflows, and secure unknown, unmanaged risks on your cloud attack surface.
ImmuniWeb is a global application security company operating in over 50 countries, headquartered in Geneva, Switzerland. Most of ImmuniWeb's customers come from regulated industries, such as banking, healthcare, and e-commerce.
ImmuniWeb® AI Platform leverages award-winning AI and Machine Learning technology for acceleration and intelligent automation of Attack Surface Management and Dark Web Monitoring. The data is later leveraged for threat-aware and risk-based Application Penetration Testing for web, mobile, and API security testing. ImmuniWeb is the only company that offers a contractual zero false-positives SLA with a money-back guarantee. ImmuniWeb’s AI technology is a recipient of numerous awards and recognitions, including Gartner Cool Vendor, IDC Innovator, and the winner of “SC Award Europe” in the “Best Usage of Machine Learning and AI” category.
ImmuniWeb® Community Edition runs over 100,000 daily tests, being one of the largest application security communities. ImmuniWeb SA is an ISO 27001 certified and CREST-accredited company.
We monitor all Attack Surface Management (ASM) reviews to prevent fraudulent reviews and keep review quality high. We do not post reviews by company employees or direct competitors. We validate each review for authenticity via cross-reference with LinkedIn, and personal follow-up with the reviewer when necessary.